205 related articles for article (PubMed ID: 33647576)
1. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
2. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
3. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
4. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
Masson L; Mlisana K; Little F; Werner L; Mkhize NN; Ronacher K; Gamieldien H; Williamson C; Mckinnon LR; Walzl G; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2014 Dec; 90(8):580-7. PubMed ID: 25107710
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
[TBL] [Abstract][Full Text] [Related]
6. The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
McKinnon LR; Achilles SL; Bradshaw CS; Burgener A; Crucitti T; Fredricks DN; Jaspan HB; Kaul R; Kaushic C; Klatt N; Kwon DS; Marrazzo JM; Masson L; McClelland RS; Ravel J; van de Wijgert JHHM; Vodstrcil LA; Tachedjian G
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):219-228. PubMed ID: 30638028
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.
Masson L; Arnold KB; Little F; Mlisana K; Lewis DA; Mkhize N; Gamieldien H; Ngcapu S; Johnson L; Lauffenburger DA; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781
[TBL] [Abstract][Full Text] [Related]
8. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
9. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
Garrett N; Mtshali A; Osman F; Masson L; McKinnon LR; Singh R; Mitchev N; Ngobese H; Kharsany ABM; Abdool Karim S; Mlisana K; Passmore JA; Rompalo A; Mindel A; Liebenberg L
Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
[TBL] [Abstract][Full Text] [Related]
10. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054
[TBL] [Abstract][Full Text] [Related]
11. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk.
Mwatelah R; McKinnon LR; Baxter C; Abdool Karim Q; Abdool Karim SS
J Int AIDS Soc; 2019 Aug; 22 Suppl 6(Suppl Suppl 6):e25346. PubMed ID: 31468677
[TBL] [Abstract][Full Text] [Related]
13. Bacterial vaginosis and the cervicovaginal immune response.
Mitchell C; Marrazzo J
Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618
[TBL] [Abstract][Full Text] [Related]
14. Genital inflammation, immune activation and risk of sexual HIV acquisition.
Passmore JA; Jaspan HB; Masson L
Curr Opin HIV AIDS; 2016 Mar; 11(2):156-62. PubMed ID: 26628324
[TBL] [Abstract][Full Text] [Related]
15. Genital tract interleukin-8 but not interleukin-1beta or interleukin-6 concentration is associated with bacterial vaginosis and its clearance in HIV-infected and HIV-uninfected women.
Losikoff P; Fichorova R; Snyder B; Rodriguez I; Cu-Uvin S; Harwell J; Mayer KH
Infect Dis Obstet Gynecol; 2007; 2007():92307. PubMed ID: 18273408
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa.
Mlisana K; Naicker N; Werner L; Roberts L; van Loggerenberg F; Baxter C; Passmore JA; Grobler AC; Sturm AW; Williamson C; Ronacher K; Walzl G; Abdool Karim SS
J Infect Dis; 2012 Jul; 206(1):6-14. PubMed ID: 22517910
[TBL] [Abstract][Full Text] [Related]
17. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
Mngomezulu K; Mzobe GF; Mtshali A; Osman F; Liebenberg LJP; Garrett N; Singh R; Rompalo A; Mindel A; Karim SSA; Karim QA; Baxter C; Ngcapu S
Front Immunol; 2021; 12():695201. PubMed ID: 34177961
[TBL] [Abstract][Full Text] [Related]
18. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
19. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells.
Masson L; Salkinder AL; Olivier AJ; McKinnon LR; Gamieldien H; Mlisana K; Scriba TJ; Lewis DA; Little F; Jaspan HB; Ronacher K; Denny L; Abdool Karim SS; Passmore JA
Immunology; 2015 Dec; 146(4):557-67. PubMed ID: 26302175
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of different screening and diagnostic strategies for sexually transmitted infections and bacterial vaginosis in women attending primary health care facilities in Cape Town.
Smith E; Masson L; Passmore JS; Sinanovic E
Front Public Health; 2023; 11():1048091. PubMed ID: 36935688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
